Helios Investment Partners

Helios Investment Partners is the largest Africa-focused private equity firm by AUM, headquartered in London with deep operating teams across Lagos, Nairobi, and Johannesburg, deploying $25M+ growth and Series C cheques into mature healthcare, telecom, and digital infrastructure assets. The firm operates a growth-with-impact mandate that combines institutional return discipline with development-finance-grade impact reporting, and its capital base includes major LPs across the US, Europe, and African development institutions. For founders, Helios is the right partner if you are running a $50M+ revenue African healthcare platform (hospital networks, diagnostic chains, pharma distribution, insurance), with audited financials, sophisticated governance, and a clear path to a billion-dollar enterprise value. AI focus is a stated emerging interest but the core investment muscle is operational consolidation and infrastructure financing rather than venture-style technology bets. Founders running early-stage digital health, deep biotech, or sub-$10M revenue platforms should not approach. The cleanest entry path is via a sell-side banker (Rothschild, Renaissance Capital, Standard Chartered), a Helios portfolio CEO, or a Tier-1 African PE intermediary. In the pitch, lead with EBITDA, capital deployment plan, multi-country expansion economics, and governance and ESG posture, because Helios’s diligence is institutional and DFI-grade. Caveats: as a PE shop, Helios will price for control or significant minority and term sheets carry standard PE governance provisions. Cycle times are months and the firm prefers proprietary processes over auctions. Founders should also be realistic about exit horizons (5-7 years) and the limited number of credible African strategic acquirers and IPO venues, which shapes valuation discipline at entry.